Tilray has added South Africa to the list of countries where it’s exporting made-in-B.C. medicinal cannabis and extracts.
“With this announcement, Tilray products are now available in nine countries on five continents,” the company’s CEO, Brendan Kennedy, said quoted in a media release. “This export is another strategic milestone as we aim to build the world’s leading medical cannabis brand. We are encouraged by the evolving regulations pertaining to cannabis in South Africa and around the world and are pleased to make our pharmaceutical-grade products available to qualified patients in need in throughout the country.”
Tilray, a Nanaimo-based company, became the first in Canada to legally export medicinal cannabis when it began shipping to partners in Europe in June 2016.
Today the list of countries where Tilray’s medicinal-cannabis is available includes Croatia, the Czech Republic, Germany, Cyprus, Australia, New Zealand, Chile, and now South Africa.
Tilray’s partner in South Africa is BGM Pharmaceuticals. The medicinal-cannabis product that its distributing there takes the form of a liquid-extract solution that’s to be taken orally via a dropper bottle.
The agreement marks Tilray’s first foray into the continent of Africa.
“Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has ever been legally exported to and made available for medical purposes in the country of South Africa and on the continent of Africa,” a Tilray media release reads.
